C. Bleux et al., A MOUSE PLACENTAL IMMUNOREGULATORY FACTOR DIFFERENT FROM TRANSFORMINGGROWTH-FACTOR-BETA, Journal of interferon & cytokine research, 15(4), 1995, pp. 351-357
Of the growth-promoting factors, transforming growth factor beta (TGF-
beta) has been most clearly shown to act as a potent regulator of infl
ammation and immunity, It is highly suppressive for T and B lymphocyte
proliferation, cytotoxic T lymphocyte generation, and lymphokine-acti
vated killer cell development, as well as natural killer cell activity
, Moreover, there is accumulating evidence that TGF-beta also may cont
ribute to impaired immune surveillance of tumor development, In previo
us work, we isolated and described a 40 kD glycoprotein extracted from
mouse placenta, This placental factor (PF) is also a potent immune mo
dulator in vivo: it is highly inhibitory of secondary antibody respons
es as well as cellular responses, such as local graft-versus-host reac
tions, Because placenta has been shown to be a major source of TGF-bet
a and several reports have indicated an important role for TGF-beta in
the immunosuppressive mechanisms taking place during the course of ma
mmalian gestation, we have looked for the presence of TGF-beta in our
placental factor preparations, Our results clearly indicate that they
do not contain TGF-beta or TGF-beta-like molecules by the following cr
iteria: (1) no inhibition of Mv-1 Lu cell proliferation at any dose te
sted; (2) no band detected by immunoblotting using different polyclona
l reagents specific for TGF-beta(1); and (3) no activity retained on o
r eluted from an affinity column made of immobilized monoclonal antibo
dy against TGF-beta(2). Aliquots of the same preparations retained the
ir full immune inhibitory capacity in vivo throughout the various assa
ys, Thus, we must conclude that the immune regulator we have isolated
is different from the TGF-beta molecule superfamily, In the light of a
ccumulating evidence for the pivotal role of TGF-beta(2) or TGF-beta(2
)-like molecules in the regulation of the maternal immune responses to
ward the fetus, the description of a new distinct molecular species wi
th immunosuppressive properties may well be of physiologic and clinica
l relevance.